These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8532669

  • 1. Interaction between a Fab fragment against gp41 of human immunodeficiency virus 1 and its peptide epitope: characterization using a peptide epitope library and molecular modeling.
    Stigler RD, Rüker F, Katinger D, Elliott G, Höhne W, Henklein P, Ho JX, Keeling K, Carter DC, Nugel E.
    Protein Eng; 1995 May; 8(5):471-9. PubMed ID: 8532669
    [Abstract] [Full Text] [Related]

  • 2. Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1.
    He XM, Rüker F, Casale E, Carter DC.
    Proc Natl Acad Sci U S A; 1992 Aug 01; 89(15):7154-8. PubMed ID: 1496010
    [Abstract] [Full Text] [Related]

  • 3. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S, Julien JP, Isenman DE, Kunert R, Katinger H, Pai EF.
    J Mol Biol; 2008 Oct 17; 382(4):910-9. PubMed ID: 18692506
    [Abstract] [Full Text] [Related]

  • 4. Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41.
    Gustchina E, Bewley CA, Clore GM.
    J Virol; 2008 Oct 17; 82(20):10032-41. PubMed ID: 18667502
    [Abstract] [Full Text] [Related]

  • 5. Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy.
    Oldstone MB, Tishon A, Lewicki H, Dyson HJ, Feher VA, Assa-Munt N, Wright PE.
    J Virol; 1991 Apr 17; 65(4):1727-34. PubMed ID: 2002540
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M, Dickey C, Cotropia JP, Gevorkian G, Larralde C, Broliden K, Levi M, Burgess A, Cao C, Weiner DB, Agadjanyan MG, Ugen KE.
    Virology; 2000 Apr 25; 270(1):135-45. PubMed ID: 10772986
    [Abstract] [Full Text] [Related]

  • 9. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus.
    Gairin JE, Madaule P, Traincard F, Barrès E, Rossier J.
    FEMS Microbiol Immunol; 1991 Apr 25; 3(2):109-19. PubMed ID: 1863470
    [Abstract] [Full Text] [Related]

  • 10. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP, Bryson S, Nieva JL, Pai EF.
    J Mol Biol; 2008 Dec 12; 384(2):377-92. PubMed ID: 18824005
    [Abstract] [Full Text] [Related]

  • 11. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.
    Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H, Burton DR, Wilson IA.
    Immunity; 2005 Feb 12; 22(2):163-73. PubMed ID: 15723805
    [Abstract] [Full Text] [Related]

  • 12. HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.
    McGaughey GB, Citron M, Danzeisen RC, Freidinger RM, Garsky VM, Hurni WM, Joyce JG, Liang X, Miller M, Shiver J, Bogusky MJ.
    Biochemistry; 2003 Mar 25; 42(11):3214-23. PubMed ID: 12641452
    [Abstract] [Full Text] [Related]

  • 13. [Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5].
    Tumanova OIu, Kuvshinov VN, Azaev MSh, Masharskiĭ AE, Klimov NA, Kozlov AP, Il'ichev AA, Sandakhchiev LS.
    Mol Biol (Mosk); 2001 Mar 25; 35(1):146-51. PubMed ID: 11234374
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R, Huarte N, Julien JP, Kunert R, Pai EF, Nieva JL.
    AIDS Res Hum Retroviruses; 2011 Aug 25; 27(8):863-76. PubMed ID: 21142698
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structure-based design of a protein immunogen that displays an HIV-1 gp41 neutralizing epitope.
    Stanfield RL, Julien JP, Pejchal R, Gach JS, Zwick MB, Wilson IA.
    J Mol Biol; 2011 Dec 02; 414(3):460-76. PubMed ID: 22033480
    [Abstract] [Full Text] [Related]

  • 19. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
    Nelson JD, Brunel FM, Jensen R, Crooks ET, Cardoso RM, Wang M, Hessell A, Wilson IA, Binley JM, Dawson PE, Burton DR, Zwick MB.
    J Virol; 2007 Apr 02; 81(8):4033-43. PubMed ID: 17287272
    [Abstract] [Full Text] [Related]

  • 20. Synthetic Fab fragments that bind the HIV-1 gp41 heptad repeat regions.
    Liu Y, Regula LK, Stewart A, Lai JR.
    Biochem Biophys Res Commun; 2011 Oct 07; 413(4):611-5. PubMed ID: 21925149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.